About Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency
Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency is a rare disease catalogued by Orphanet (ORPHA:363432). It is associated with the GRID2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency trials.
Search ClinicalTrials.gov for "Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency" or filter by Orphanet code ORPHA:363432 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency. Updated daily.